Privia Health Group, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $2.12B | $1.74B | $1.66B | $1.36B | $966.2M | $817.1M | $786.4M |
| Cost of Revenue | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | — |
| SG&A Expense | $138.2M | $126.2M | $109.6M | $129.6M | $255.9M | $44.0M | $41.8M |
| Operating Income | $34.2M | $17.0M | $20.6M | $-19.1M | $-217.4M | $25.4M | $16.1M |
| Operating Margin | 1.6% | 1.0% | 1.2% | -1.4% | -22.5% | 3.1% | 2.0% |
| Interest Expense | — | — | — | $500.0K | $1.1M | $1.9M | $4.0M |
| Pretax Income | $43.9M | $27.9M | $29.0M | $-18.6M | $-218.5M | $23.5M | $9.2M |
| Income Tax Expense | $14.2M | $10.8M | $8.0M | $-6.5M | $-27.9M | $-7.4M | $1.2M |
| Net Income | $22.9M | $14.4M | $23.1M | $-8.6M | $-188.2M | $31.2M | $8.2M |
| Net Margin | 1.1% | 0.8% | 1.4% | -0.6% | -19.5% | 3.8% | 1.0% |
| EPS (Basic) | $0.19 | $0.12 | $0.20 | $-0.08 | $-1.83 | $0.33 | $0.09 |
| EPS (Diluted) | $0.18 | $0.11 | $0.19 | $-0.08 | $-1.83 | $0.33 | $0.09 |
| Shares Outstanding (Basic) | 122.2M | 119.4M | 116.7M | 110.7M | 103.0M | 96.0M | 95.9M |
| Shares Outstanding (Diluted) | 128.9M | 125.6M | 124.7M | 110.7M | 103.0M | 96.0M | 95.9M |
| Dividends Per Share | — | — | — | — | — | — | — |